Fluent Biosciences is developing technology to allow molecular analysis of cells without complex microfluidic equipment. Single-cell (sc) biology enables researchers to explore the heterogeneity within cell populations but it is limited by high-costs, tricky procedures and scalability. Fluent is creating scRNA-seq solutions from cell capture through to data analysis which can facilitate studies across cancer, immunology, neuroscience and infectious disease. These solutions make use of Fluent’s breakthrough technology called Particle-Templated Instant Partitions (PIPseqTM). PIPseqTM enables sensitive and unbiased preparation of proteins and nucleic acids for sequencing applications without complex instrumentation.

Fluent BioSciences

Founded: 2018
Location: Watertown, MA
Employee range: 11 - 50
Funding: 10-100M

Short description:

Drug notes:

Long description:

Jobs: